3Kawamura T. Current advancement of assay of tumor markers and the perspective in future. Nippon Rinsho,.1996, 54: 1642-1648.
4Ochi Y, Okabe H, Inui T, et al. Tumor marker-present and future. Rinsho Byori, 1997, 45: 875-883.
5Yamamoto H, Miyake Y, Noura S, et al. Tumor markers for colorectal cancer. Gan To Kagaku Ryoho, 2001, 28:1299-1305.
6Gebauer G, Muller RW. Tumor marker concetratios in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Anticancer Res,1997, 17:2939-2942.
7Reiter W ,Stieber P ,Reuter C ,et al. Multiveriate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res, 2000, 20:5195-5198.
8Gebauer G, Muller RW. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer. Cancer Detect Prey, 2001, 25: 344-351.
9Holubec LJ ,Toplocan O ,Pikner R ,et al. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Anticancer Res, 2000,20: 5237-5244.
10Walach N, Gur Y. Leukocyte alkaline phosphatase,CA15-3, CA125, and CEA in cancer patients. Tumori,1998, 84: 360-363.
7Ko J, Lee Y H, Hwang S Y, et al. Identification and differenti al expression of novel human cervical cancer oncogene HCCR -1 -2 in human cancers and its involvement in P53 stabilization[J]. Oncogene, 2003, 22: 4679-4689.
8Chung Y J, Kim J W. Novel oncogene HCCR-1 : its diagnostic and therapeutic implications for cancer[J]. Histol Histopathol, 2005, 20:999 -1003.
9Jung S S, Park H S, Lee I J, et al. The HCCR-1 Oncoprotein as a Biomarker for Human Breast Cancer[J]. Clln Cancer Res, 2005, 11(21): 7700-7708.
10Shin S M, Chung Y J, Oh S T, et al. HCCR-1-1-Interacting Molecule "Deleted in Polyposis 1" Plays a Tumor-Suppressor Role in Colon Carcinogenesis[J]. Gastroenterology, 2006, 130(7):2074-2086.
